2018 Pan Pacific Lymphoma Conference

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

2018 Pan Pacific Lymphoma Conference

Bench to Bedside
Novel Therapies in Lymphoma
High Grade B-cell Lymphoma
Aggressive T-Cell Lymphoma
Hodgkin Lymphoma
Multiple Myeloma/Plasma Cell Dyscrasia
Common Indolent Lymphoma
Uncommon Indolent Lymphoma
Interprofessional Educational Day

Playback speed

10 seconds

Optimum Therapy for Standard Risk High Grade - DLBCL

By 2018 Pan Pacific Lymphoma Conference FEATURING Nancy L. Bartlett

0 views

August 15, 2018

Comments 0

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

High Grade B-cell Lymphoma

19:22

2018 Pan Pacific Lymphoma Conference

Challenges of Treating HGBCL Patients with Comorbidities: Anthracycl…

Feat. L. Sehn

17:51

2018 Pan Pacific Lymphoma Conference

Optimum Therapy for Standard Risk High Grade - DLBCL

Feat. N. Bartlett

10:46

2018 Pan Pacific Lymphoma Conference

New Approaches to Initial treatment of DLBCL: R-CHOP +

Feat. N. Bartlett

15:30

2018 Pan Pacific Lymphoma Conference

Challenges of Treating HGBCL Patients with Comorbidities: Who is &qu…

Feat. L. Sehn

21:17

2018 Pan Pacific Lymphoma Conference

Burkitt Lymphoma- R-Epoch for All?

Feat. M. Roschewski

08:52

2018 Pan Pacific Lymphoma Conference

Concurrent Systemic and CNS Aggressive NHL: How to Manage?

Feat. P. Bierman

26:03

2018 Pan Pacific Lymphoma Conference

Therapy for Double/Triple Hit-HGBCL

Feat. S. Smith

25:59

2018 Pan Pacific Lymphoma Conference

There is a Role for Lymphoma HDT/ASCT in the New Era of CAR T-cells!

Feat. C. Moskowitz

16:20

2018 Pan Pacific Lymphoma Conference

Is there a role for upfront transplantation in CNS Aggressive NHL

Feat. P. Bierman